Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
study ends around
Principal Investigator
by Sammy Elmariah, MD

Description

Summary

The objective of this randomized controlled trial (RCT) is to compare the clinical outcome of MitraClip™ device versus surgical repair in patients with severe primary MR who are at moderate surgical risk and whose mitral valve has been determined to be suitable for correction by MV repair surgery by the cardiac surgeon on the local site heart team.

Official Title

Percutaneous MitraClip Device or Surgical Mitral Valve REpair in PAtients With PrImaRy MItral Regurgitation Who Are Candidates for Surgery (REPAIR MR)

Keywords

Mitral Valve Regurgitation, MitraClip, Mitral Valve Insufficiency, MitraClip™ device implantation, Mitral Valve Repair Surgery

Eligibility

Locations

  • University of California at San Francisco accepting new patients
    San Francisco California 94143 United States
  • Stanford University Medical Center accepting new patients
    Stanford California 94305 United States

Lead Scientist at UCSF

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Abbott Medical Devices
ID
NCT04198870
Study Type
Interventional
Participants
Expecting 500 study participants
Last Updated